Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takehiro Nakao
Observed names:
Nakao Takehiro,
T. Nakao,
TAKEHIRO NAKAO
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Nihon University,
National Cancer Centre Japan,
The Cancer Institute Hospital,
National Cancer Center Hospital East,
Nihon University Itabashi Hospital,
Japanese Foundation For Cancer Research,
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
show all 7
OpenAlex ID:
A5110515647
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer
2022
·
Hiromichi Nakajima
, Kenichi Harano
, et al.
·
The Breast
·
27
PDF
Safety and efficacy of mucosal immunotherapy using human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine for the treatment of high-grade squamous intraepithelial lesion (HSIL): the study protocol of a randomized placebo-controlled clinical trial (MILACLE study)
2019
·
Yuji Ikeda
, Yukari Uemura
, et al.
·
Japanese Journal of Clinical Oncology
·
22
Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation
2021
·
Toru Mukohara
, Ako Hosono
, et al.
·
The Oncologist
·
17
PDF
Reconstructed uterine length is critical for the prevention of cervical stenosis following abdominal trachelectomy in cervical cancer patients
2020
·
Takahiro Nakajima
, Akiko Kasuga
, et al.
·
Journal of obstetrics and gynaecology research
·
15
Expression of Angiotensin II Types 1 and 2 Receptors in Endometriotic Lesions
2016
·
Takehiro Nakao
, Fumihisa Chishima
, et al.
·
Gynecologic and Obstetric Investigation
·
15
PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells
2025
·
Misato Kamii
, Ryo Kamata
, et al.
·
Scientific Reports
·
13
PDF
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer
2024
·
Gaku Yamamoto
, Kosuke Tanaka
, et al.
·
Cancer Letters
·
13
Neoadjuvant combination treatment of olaparib and pembrolizumab for patients with HRD-positive advanced ovarian cancer.
2024
·
Kenichi Harano
, Takehiro Nakao
, et al.
·
Journal of Clinical Oncology
·
9
PDF
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study
2022
·
Chikako Funasaka
, Yoichi Naito
, et al.
·
Japanese Journal of Clinical Oncology
·
9
PDF
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis
2021
·
Chikako Funasaka
, Yoichi Naito
, et al.
·
The Breast
·
9
PDF
The Expression of MAS1, an Angiotensin (1–7) Receptor, in the Eutopic Proliferative Endometria of Endometriosis Patients
2018
·
Takahiro Nakajima
, Fumihisa Chishima
, et al.
·
Gynecologic and Obstetric Investigation
·
5
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
2025
·
Chikako Funasaka
, Takahiro Kogawa
, et al.
·
Cancer Treatment and Research Communications
·
4
Brachytherapy for cervical cancer in septate uterus: Dose-volume differences with tandem implant placement in right vs. left uterine canal: A case report
2018
·
Naoya Ishibashi
, Toshiya Maebayashi
, et al.
·
Oncology Letters
·
4
PDF
The impact of the COVID ‐19 pandemic on perioperative chemotherapy for breast cancer
2023
·
Kaede Baba
, Megumi Kawamoto
, et al.
·
Cancer Medicine
·
3
PDF
The Inflammatory Process and Successful Implantation
2017
·
Fumihisa Chishima
, Takahiro Nakajima
, et al.
·
Journal of Mammalian Ova Research
·
3
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series
2023
·
Mao Uematsu
, Hiromichi Nakajima
, et al.
·
Melanoma Research
·
2
Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer
2022
·
KUMI NIGUMA
, KANAKO MAMISHIN
, et al.
·
Anticancer Research
·
2
Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis
2021
·
KANAKO MAMISHIN
, YOICHI NAITO
, et al.
·
Anticancer Research
·
2
PDF
NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib
2025
·
Nakano Kenji
, Oki Ryosuke
, et al.
·
International Cancer Conference Journal
·
1
Uterine corpus tumor with neuroectodermal differentiation and frequent ganglion-like cells in a postmenopausal woman
2018
·
Taku Homma
, Takehiro Nakao
, et al.
·
Gynecologic Oncology Reports
·
1
PDF
Expressions of prostaglandin E2 synthases and its related factors in local lesions of endometriosis patients
2015
·
Fumihisa Chishima
, Takehiro Nakao
, et al.
·
Journal of Reproductive Immunology
·
1
Clinical benefits of early-phase clinical trials for rare malignancies: Asian single-center analysis.
2026
·
Akihiro Ohmoto
, Takahiro Kogawa
, et al.
·
Journal of Clinical Oncology
54P Impact of treatment sequence between immune checkpoint inhibitors and paclitaxel/cetuximab in recurrent or metastatic head and neck cancer
2026
·
E. Toda
, J. Yoshida
, et al.
·
ESMO rare cancers.
PDF
Prognostic Value of Tertiary Lymphoid Structures in Epithelial Ovarian Carcinoma
2025
·
Takehiro Nakao
, Kenichi Harano
, et al.
·
Anticancer Research
PDF
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
2025
·
Shu Kato
, Kaede Baba
, et al.
·
Cancer Medicine
Show more works
View as search
Works count:
44
Citation count:
177
H-index:
9
I10-index:
7
Year
Topic
Type